TNFRSF11B and osteoporosis: Oral melatonin (15 mg/mL/day) elevated the OPG/RANKL (25 kDa) ratio and p‐ERK1/2, p‐ERK5, and RUNX2 levels in bone, mitigating OVX‐induced osteoporosis [7].